Happy Media

The Dawn June 24, 2020 A senior administration official told journalists the move would affect 525,000 jobs in the US, which is currently reeling from a high unemployment rate caused by the coronavirus pandemic.  Trump had repeatedly touted a strong economy, but now finds himself desperate for a political boost ahead of the November election.  The executive order, signed on Monday afternoon, will extend and widen the 60-day freeze Trump placed on new work permits for non-US citizens two months ago. The administration official said the new order would extend to the end of 2020 and include H-1B visas provided to 85,000 workers each year with special skills, many of them joining the US technology industry.  It will also cover most J visas, common for academics and researchers, and L visas used by companies to shift workers based overseas to their US offices.  Google CEO Sundar Pichai — whose company has been a leading beneficiary of the H1-B visa system — said...

Hindustan Times Dated 01, 2020 Prashasati Singh Police fired tear gas outside the White House late Sunday as major US cities were put under curfew to suppress rioting as anti-racism protestors again took to the streets to voice fury at police brutality. With the Trump administration branding instigators of six nights of rioting as domestic terrorists, there were more confrontations between protestors and police and fresh outbreaks of looting. Violent clashes erupted repeatedly  in a small park next to the White House, with authorities using tear gas, pepper spray and flash bang grenades to disperse crowds who lit several large fires and damaged property. Local US leaders appealed to citizens to give constructive outlet to their rage over the death of an unarmed black man in Minneapolis, while night-time curfews were imposed in cities including Washington, Los Angeles and Houston. One closely watched protest was outside the state capitol in Minneapolis’ twin city of St...

Firstpost May 29, 2020 New Delhi:  Glenmark Pharmaceuticals on Wednesday said its subsidiary has received approval from the US health regulator to market Chlorzoxazone tablets, used to treat muscle pain, in the American market. Glenmark Pharmaceuticals Inc, USA has been granted final approval by the US Food and Drug Administration (USFDA) for Chlorzoxazone tablets USP, in the strength of 375 mg and 750 mg, the drug maker said in a statement. This marks company's first abbreviated new drug application (ANDA) approval out of its new North American manufacturing facility based in Monroe, North Carolina, it added. According to IQVIATM sales data, for the 12 month period ending March 2020, the Chlorzoxazone had annual sales of around $20.9 million. Glenmark's current portfolio now consists of 163 products authorised for distribution in the US while 45 ANDAs are pending with the USFDA, the company said. In addition to these internal filings, the company continues t...